India Britain covid-19 information vaccine patient India Britain

Oxford COVID-19 vaccine trial to halt in India? 'Will abide by DCGI instructions,' says Serum Institute

Reading now: 909
www.livemint.com

Serum Institute of India (SII) on Wednesday said that drugmaker will follow the central drug regulator's instruction on suspension of the Oxford-AstraZeneca COVID-19 vaccine trial in India.The Drugs Controller General of India (DCGIon Wednesday issued a show-cause notice to Serum Institute of India for not informing it about pharma giant AstraZeneca pausing the clinical trials of the Oxford vaccine candidate for COVID-19 in other countries.On September 8, the clinical trials of one of the Oxford-AstraZeneca's COVID-19 vaccine were suspended in the United Kingdom after a participant developed an unexplained illness.In his show-cause notice, Dr V G Somani asked SII as to why the permission granted for conducting phase 2 and 3 clinical trials.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA